|
1
|
Craig JP, Nichols KK, Akpek EK, Caffery B,
Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K and
Stapleton F: TFOS DEWS II definition and classification report.
Ocul Surf. 15:276–283. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wolffsohn JS, Arita R, Chalmers R,
Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S,
Pult H, et al: TFOS DEWS II diagnostic methodology report. Ocul
Surf. 15:539–574. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Stapleton F, Alves M, Bunya VY, Jalbert I,
Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et
al: TFOS DEWS II epidemiology report. Ocul Surf. 15:334–365.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zemanová M: Dry eye disease. A review.
Cesk Slov Oftalmol. 77:107–119. 2021.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Harrell CR, Feulner L, Djonov V, Pavlovic
D and Volarevic V: The molecular mechanisms responsible for tear
hyperosmolarity-induced pathological changes in the eyes of dry eye
disease patients. Cells. 12(2755)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vehof J, Snieder H, Jansonius N and
Hammond CJ: Prevalence and risk factors of dry eye in 79,866
participants of the population-based Lifelines cohort study in the
Netherlands. Ocul Surf. 19:83–93. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu J, Duan C, Yang Y, Wang Z, Tan C, Han C
and Hou X: Insights into the liver-eyes connections, from
epidemiological, mechanical studies to clinical translation. J
Transl Med. 21(712)2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Patel R, Nair S, Choudhry H, Jaffry M and
Dastjerdi M: Ocular manifestations of liver disease: An important
diagnostic aid. Int Ophthalmol. 44(177)2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rishi A, Ashish J, Rashmi K and Sushil F:
Ocular Manifestations and Endothelial cell density in Chronic Liver
Disease Patients and its Co-relation with Severity of Liver
Disease. Trop Gastroenterol. 46:71–76. 2025.
|
|
10
|
Sajovic J, Meglič A, Glavač D, Markelj Š,
Hawlina M and Fakin A: The role of vitamin A in retinal diseases.
Int J Mol Sci. 23(1014)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kopecký A, Benda F and Němčanský J:
Xerosis in patient with vitamin A deficiency-a case report. Cesk
Slov Oftalmol. 73:222–224. 2018.PubMed/NCBI
|
|
12
|
Rajappa M, Goyal A and Kaur J: Inherited
metabolic disorders involving the eye: A clinico-biochemical
perspective. Eye (Lond). 24:507–518. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Prasad D and Bhriguvanshi A: Ocular
manifestations of liver disease in children: Clinical aspects and
implications. Ann Hepatol. 19:608–613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gifford FJ, Moroni F, Farrah TE,
Hetherington K, MacGillivray TJ, Hayes PC, Dhaun N and Fallowfield
JA: The eye as a non-invasive window to the microcirculation in
liver cirrhosis: A prospective pilot study. J Clin Med.
9(3332)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fortea JI, Carrera IG, Puente A and Crespo
J: Hepatic cirrhosis. Medicine (Barcelona). 13:297–307. 2020.
|
|
16
|
Sabry RM, Hamad O, Khalil HEM, Mohammed
SI, Eid RA and Hosny H: The role of multifocal visual evoked
potential in detection of minimal hepatic encephalopathy in
patients with compensated liver cirrhosis. BMC Neurol.
25(45)2025.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Parmar UPS, Morya AK, Gupta PC, Arora A
and Verma N: Role of artificial intelligence-based ocular
biomarkers in hepatobiliary diseases: A scoping review. World J
Hepatol. 17(109801)2025.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Alshahrani S, Aljumah AA and Alluhaidan A:
Uveitis and autoimmune hepatitis, a real entity? A case report with
review of the literature. Saudi J Ophthalmol. 35:73–77.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jacobi C, Wenkel H, Jacobi A, Korn K,
Cursiefen C and Kruse FE: Hepatitis C and ocular surface disease.
Am J Ophthalmol. 144:705–711. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Abd El-Badie Mohamed M and Abd-El Azeem
Eed K: Retinopathy associated with interferon therapy in patients
with hepatitis C virus. Clin Ophthalmol. 6:1341–1345.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bertrand RHC, Bertrand ALX, Gomes TM and
Ferreira ASP: An eye on hepatitis C: A review. Arq Bras Oftalmol.
82:161–167. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Iqbal S, Ahmed I and Azam A: Proportion of
dry eye in hepatitis C patients. Pak J Ophthalmol. 34:286–289.
2018.
|
|
23
|
Fang SL, Teo L, Loo CY, Li JW and Santosa
A: Lessons of the month 2: Ocular manifestations and complications
of hepatitis C infection. Clin Med (Lond). 21:e417–e419.
2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cacoub P, Renou C, Rosenthal E, Cohen P,
Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P,
Musset L, et al: Extrahepatic manifestations associated with
hepatitis C virus infection. A prospective multicenter study of 321
patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine
Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.
Medicine (Baltimore). 79:47–56. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yeh CC, Wang WC, Wu CS, Sung FC, Su CT,
Shieh YH, Chang SN and Su FH: Association of Sjögrens Syndrome in
patients with chronic hepatitis virus infection: A population-based
analysis. PLoS One. 11(e0161958)2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gumus K, Yurci A, Mirza E, Arda H, Oner A,
Topaktas D and Karakucuk S: Evaluation of ocular surface damage and
dry eye status in chronic hepatitis C at different stages of
hepatic fibrosis. Cornea. 28:997–1002. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Martín LL, Rocha-de-Lossada C,
Marín-Martínez S and Peraza-Nieves JE: Sterile, recurrent, and
bilateral corneal perforation related to primary biliary cirrhosis
complicated by secondary Sjögren syndrome and vitamin A deficiency.
Arq Bras Oftalmol. 84:606–609. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Selmi C and Gershwin ME: Chronic
autoimmune epithelitis in Sjögren's Syndrome and primary biliary
cholangitis: A comprehensive review. Rheumatol Ther. 4:263–279.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Efe C, Ozaslan E, Purnak T, Ozbalkan Z and
Altiparmak E: Uveitis in patients with autoimmune hepatitis. Am J
Ophthalmol. 149:684–685; author reply 685. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Linzay CD, Sharma B and Pandit S:
Autoimmune Hepatitis. In: StatPearls [Internet]. StatPearls
Publishing, Treasure Island, FL, 2026.
|
|
31
|
In: StatPearls [Internet]. Treasure Island
(FL). StatPearls Publishing; 2026. Citirik M, Berker N, Kacar S and
Kekilli M: Ocular findings in patients with autoimmune liver
disease. Ocul Immunol Inflamm. 20:438–442. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Romanelli RG, La Villa G, Almerigogna F,
Vizzutti F, Di Pietro E, Fedi V, Gentilini P and Laffi G: Uveitis
in autoimmune hepatitis: A case report. World J Gastroenterol.
12:1637–1640. 2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Roh HC, Lee JK, Kim M, Oh JH, Chang MW,
Chuck RS and Park CY: Systemic comorbidities of dry eye Syndrome:
The Korean National health and nutrition examination survey V, 2010
to 2012. Cornea. 35:187–192. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chun YH, Kim HR, Han K, Park YG, Song HJ
and Na KS: Total cholesterol and lipoprotein composition are
associated with dry eye disease in Korean women. Lipids Health Dis.
12(84)2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Park HW and Park JW: The Association
between symptoms of dry eye Syndrome and metabolic outcome in a
general population in Korea. J Korean Med Sci. 31:1121–1126.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rathnakumar K, Ramachandran K, Baba D,
Ramesh V, Anebaracy V, Vidhya R, Vinothkumar R, Poovitha R and
Geetha R: Prevalence of dry eye disease and its association with
dyslipidemia. J Basic Clin Physiol Pharmacol. 29:195–199.
2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Posa A, Sel S, Dietz R, Sander R, Paulsen
F, Bräuer L and Hammer C: Historical profiling of dry eye
patients-potential trigger factors and comorbidities. Klin Monbl
Augenheilkd. 241:110–118. 2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li Y, Xie L, Song W, Chen S, Cheng Y, Gao
Y, Huang M, Yan X and Yang S: Association between dyslipidaemia and
dry eye disease: A systematic review and meta-analysis. BMJ Open.
13(e069283)2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wang TH, Tsai YJ, Wang YH, Wu CL and Lin
IC: Relationship between dry eye disease and dyslipidemia: A
systematic review. J Clin Med. 12(6631)2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Serrano-Morales JM, Álvarez-Santaliestra
N, Sánchez-González MC, Ballesteros-Sánchez A and Sánchez-González
JM: Impact of dyslipidemia on tear film and meibomian gland
dysfunction: A cross-sectional study of the interplay between serum
lipid profile and ocular surface health. J Ophthalmol.
2024(7345270)2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yang Y, Zhang R, Zhang M, Yang Z, Ma Z,
Zhang Y, Wu M, Guo D and Bi H: Association between disorders of
lipid metabolism and oculopathy: An overview. Int J Med Sci.
22:3878–3894. 2025.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Vitiello L, De Bernardo M, Guercio Nuzio
S, Mandato C, Rosa N and Vajro P: Pediatric liver diseases and
ocular changes: What hepatologists and ophthalmologists should know
and share with each other. Dig Liver Dis. 52:1–8. 2020.PubMed/NCBI View Article : Google Scholar
|
